Comparison - TRIB - NASDAQ

Weiss Ratings	TRIB - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Rating	E
Reward Index	Very Weak
Risk Index	Weak
Risk Grade	D-
Reward Grade	E

Rating Factors	TRIB - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	Fair
Efficiency Index	Very Weak
Solvency Index	Very Weak
Total Return Index	Very Weak
Volatility Index	Weak

Beta / Standard Deviation	TRIB - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Beta	0.32

Price History	TRIB - NASDAQ	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	-2.36%
30-Day Total Return	-50.06%
60-Day Total Return	-24.53%
90-Day Total Return	-66.38%
Year to Date Total Return	-28.50%
1-Year Total Return	-70.21%
2-Year Total Return	-85.85%
3-Year Total Return	-85.40%
5-Year Total Return	-86.94%
52-Week High % Change	-79.21%
52-Week Low % Change	18.06%

Price	TRIB - NASDAQ	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$3.55
52-Week Low Price	$0.63
52-Week Low Price (Date)	Mar 04, 2025
52-Week High Price (Date)	Jun 12, 2024

Valuation	TRIB - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Market Cap	12.86M
Enterprise Value	103.74M
Price/Earnings (TTM)	--
Earnings Per Share (TTM)	-46.21
Earnings Per Share Growth	-42.25%
Price/Earnings To Growth	--
Price/Sales (TTM)	0.01
Price/Book (Q)	-0.01
Enterprise Value/Revenue (TTM)	2.36
Price	$0.68
Enterprise Value/EBITDA (TTM)	-11.77
Enterprise Value/EBIT	-10.74
Market Cap Category	Nano Cap

Dividends and Shares	TRIB - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	473.20K
Dividend Yield	--
Div. Per Share (Most Recent)	$1.10
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	$1.10

Company Info	TRIB - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Phone Number	353 1 276 9800
Address	--
Website	www.trinitybiotech.com
Country	Ireland
Year Founded	1992

Profitability	TRIB - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	--
Profit Margin	--

Management Effectiveness	TRIB - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Return on Assets	--
Return on Equity	--

Income Statement	TRIB - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	--
Total Revenue (TTM)	--
Revenue Per Share	$92.87
Gross Profit (TTM)	--
EBITDA (TTM)	--
EBIT (TTM)	--
Net Income (TTM)	--
Net Income Avl. to Common (TTM)	--
Total Revenue Growth (Q YOY)	13.99%
Earnings Growth (Q YOY)	63.17%
EPS Diluted (TTM)	--
EPS Diluted Growth (Q YOY)	8.72%

Balance Sheet	TRIB - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	5.32M
Cash Per Share (Q)	$11.24
Total Current Assets (Q)	45.98M
Total Preferred Equity (Q)	--
Total Equity (Q)	-29.40M
Current Ratio (Q)	1.784
Book Value Per Share (Q)	-$62.12
Total Assets (Q)	94.36M
Total Current Liabilities (Q)	25.77M
Total Debt (Q)	93.34M
Total Liabilities (Q)	123.76M
Total Common Equity (Q)	-29.40M

Cash Flow	TRIB - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	--
Cash from Financing (TTM)	--
Net Change in Cash (TTM)	--
Levered Free Cash Flow (TTM)	--
Cash from Operations (TTM)	--